Table 1.
Kaplan-Meier postoperative survival analysis (log-rank test) according to clinical-pathological factors of patients with early-stage NSCLC.
Figure 1.
Relative frequencies for recurrence sites for postoperative early-stage NSCLC.
Figure 2.
Recurrence-free survival for patients in early-stage NSCLC.
Figure 3.
Recurrence-free survival for patients in early-stage NSCLC according to adjuvant chemotherapy.
Table 2.
Results of multivariate survival analyses of Recurrence-free survival (RFS) according to the Cox regression model.
Figure 4.
Annual recurrence hazard rates for patients in early-stage NSCLC.
Table 3.
Patterns of recurrence after surgery.
Figure 5.
Recurrence hazard rates according to clinic-pathological characteristics.
A: age; B: grade of histological differentiation; C: smoking history; D: visceral pleural invasion; E: tumor diameter; F: level of CEA; G: number of dissected lymph nodes; H: stations of dissected lymph nodes.
Figure 6.
Recurrence hazard rates for patients in early-stage NSCLC according to adjuvant chemotherapy.